Status:
COMPLETED
Usage of Meropenem/Gentamicin Versus Ceftazidime/Avibactam in ARDS
Lead Sponsor:
King Abdul Aziz Specialist Hospital
Conditions:
Ventilator Associated Pneumonia
Eligibility:
All Genders
18-65 years
Brief Summary
This was a prospective double blind study conducted on 200 polytrauma patients admitted to King Abdul-Aziz Specialized Hospital, Taif, KSA between July 2018 and December 2019 in surgical ICU. All pati...
Detailed Description
Patients of Group A received meropenem one gram slowly IV infusion every 8 hours for 14 days and gentamicin 7 milligram (mg)/ Kilogram body weight per day slowly IV infusion once daily only for one we...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- patients with respiratory failure diagnosed by ABG,chest Xray, and clinical by Arterial oxygen low saturation.
- Exclusion Criteria:
- Any other types of respiratory failure rather than trauma
Exclusion
Key Trial Info
Start Date :
July 5 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2019
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04402359
Start Date
July 5 2018
End Date
December 30 2019
Last Update
June 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
King abd el Aziz specialist hospital
Ta'if, Saudi Arabia, 21944